- Aurora Cannabis (ACB, Financial) has widened its compassionate pricing program by raising the income eligibility threshold from $40,000 to $60,000 CAD.
- This expansion potentially benefits over 50% of Canada's adult population.
- New medical cannabis products have been launched, including CBD and THC options.
Aurora Cannabis Inc. (NASDAQ: ACB) has announced an expansion of its compassionate pricing program for medical cannabis in Canada. The company has increased the annual income eligibility threshold from $40,000 to $60,000 CAD, making it the most inclusive medical cannabis pricing program in the country. This strategic move is set to benefit over half of the adult population in Canada, according to the company.
In conjunction with this program extension, Aurora has introduced three new medical cannabis products. These include Aurora | Mediora Minis, a Cannatonic CBD flower, Daily Special | Sativa J's, THC pre-rolls, and WMMC | Seasonal Stash Petro Biscuit, a THC flower. These additions aim to cater to a broader range of medical needs and preferences.
Aurora continues to provide tailored resources for special demographic groups such as seniors, pediatric patients, veterans, and first responders, reinforcing their commitment to accessible medical cannabis. The company emphasizes its role in breaking down barriers to high-quality cannabis, empowering patients to explore various treatment options.
For further details and support, patients are encouraged to visit Aurora's medical website, where they can connect with the client care team. Aurora's dedication to innovation in the medical cannabis sector is evident in these initiatives, reinforcing their market leadership in Canada.
